Nuvation Bio Ownership | Who Owns Nuvation Bio?
Nuvation Bio Ownership Summary
Nuvation Bio is owned by 65.57% institutional investors, 26.85% insiders, and 7.58% retail investors. Fmr is the largest institutional shareholder, holding 16.55% of NUVB shares.
NUVB Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Nuvation Bio | 65.57% | 26.85% | 7.58% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Fmr | 45.29M | 16.55% | $120.46M |
Decheng capital | 25.95M | 9.49% | $69.04M |
Blackrock | 16.24M | 7.41% | $47.41M |
Blackrock funding, inc. /de | 18.54M | 6.78% | $49.32M |
Omega fund management | 13.28M | 6.06% | $38.77M |
Vanguard group | 15.73M | 5.75% | $41.85M |
Octagon capital advisors lp | 9.20M | 3.36% | $24.48M |
Laurion capital management lp | 6.49M | 2.37% | $17.27M |
State street | 3.98M | 1.81% | $11.61M |
Geode capital management | 4.95M | 1.81% | $13.17M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Omega fund management | 13.28M | 28.72% | $38.77M |
Decheng capital | 25.95M | 14.81% | $69.04M |
Octagon capital advisors lp | 9.20M | 4.03% | $24.48M |
Edbi pte | 1.27M | 3.58% | $3.38M |
Aisling capital management lp | 2.54M | 2.40% | $6.76M |
Bioimpact capital | 4.16M | 1.57% | $11.08M |
Ghost tree capital | 1.15M | 1.05% | $3.36M |
Tang capital management | 3.90M | 0.69% | $10.37M |
Redmile group | 3.03M | 0.56% | $8.06M |
Sio capital management | 668.12K | 0.50% | $1.78M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Fmr | 45.29M | 0.01% | 16.05M |
Vanguard group | 15.73M | 0.00% | 4.91M |
Laurion capital management lp | 6.49M | 0.32% | 4.90M |
Bioimpact capital | 4.16M | 1.57% | 4.16M |
Blackrock | 16.24M | 0.00% | 3.71M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ecor1 capital | - | - | -19.21M |
Octagon capital advisors lp | 9.20M | 4.03% | -2.97M |
Awm investment company | - | - | -1.35M |
Omega fund management | 13.28M | 28.72% | -796.46K |
Acadian asset management | - | - | -653.18K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Bioimpact capital | 4.16M | 1.57% | 4.16M | $11.08M |
Ghost tree capital | 1.15M | 1.05% | 1.15M | $3.36M |
Alps advisors | 272.15K | 0.00% | 272.15K | $723.92K |
Susquehanna fundamental investments | 215.20K | 0.01% | 215.20K | $572.43K |
Meridian wealth management | 56.34K | 0.02% | 56.34K | $164.53K |
Sold Out
Holder | Change |
---|---|
National bank of canada /fi/ | -7.00 |
Nelson, van denburg & campbell wealth management group | -28.00 |
Lindbrook capital | -154.00 |
Capital performance advisors llp | -281.00 |
Covestor | -384.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 148 | -5.13% | 179,374,596 | -4.45% | 65 | 1.39% | 83 | -3.49% | 35 | -2.78% |
Sep 30, 2024 | 155 | 4.73% | 187,725,271 | 23.08% | 68 | 1.42% | 86 | -1.15% | 36 | -5.26% |
Jun 30, 2024 | 148 | 19.35% | 152,519,595 | 13.28% | 69 | 1.84% | 87 | 29.85% | 38 | - |
Mar 31, 2024 | 124 | 5.98% | 134,638,130 | 0.28% | 61 | 1.64% | 67 | 19.64% | 38 | 11.76% |
Dec 31, 2023 | 117 | -7.14% | 134,256,521 | -2.00% | 61 | 1.56% | 56 | -11.11% | 34 | -2.86% |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Apr 07, 2025 | Hung David | PRESIDENT AND CEO | Buy | $487.50K |
Apr 04, 2025 | Hung David | PRESIDENT AND CEO | Buy | $332.72K |
Apr 01, 2025 | Mashal Robert | - | Buy | $165.15K |
Apr 01, 2025 | Mashal Robert | - | Buy | $1.83K |
Nov 11, 2024 | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | Sell | $162.88K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | 4 | - |
2025 Q1 | - | - |
2024 Q4 | 2 | 1 |
2024 Q3 | - | - |
2024 Q2 | 5 | - |
NUVB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools